It is administered as a small subcutaneous injection, typically once daily, and is most often deployed in 6 to 12 week structured cycles under medical supervision
For a thorough understanding of peptide safety considerations, see our peptide safety guide
improved recovery in crush injury models (PMID: 31266512) Bone: Accelerated fracture healing and pseudoarthrosis repair in animal models (PMID: 10071911) Muscle: Faster recovery from muscle crush injuries and systemic corticosteroid-induced damage (PMID: 40756949) TB-500 Research Evidence TB-500 is a synthetic fragment of Thymosin Beta-4, often used as an alternative to the full-length protein
Abeta40 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway
document solvent, concentration, and prep date Minimize moisture and airborne contamination during weighing Follow institutional SOPs and appropriate containment Restrictions Laboratory research use only No clinical or veterinary applications No therapeutic or diagnostic claims Technical Specifications Storage & Notes Record lot, solvent system, concentration, and preparation date